Impacts of Man-Made Isotope Production and Nuclear Reactors

  • Achim, P., et al., Contribution of isotopes production facilities and nuclear power plants to the Xe-133 worldwide atmospheric background. CTBT Science and Technology, Vienna, Austria, 2011: p. 8-10.
  • Bowyer, Eslinger, Cameron, Friese, Hayes, Metz, et al. (2014). Potential impact of releases from a new Molybdenum-99 production facility on regional measurements of airborne xenon isotopes. Journal of Environmental Radioactivity, 129, 43-47.
  • Bowyer, Kephart, Eslinger, Friese, Miley, & Saey (2013). Maximum reasonable radioxenon releases from medical isotope production facilities and their effect on monitoring nuclear explosions. Journal of Environmental Radioactivity, 115, 192-200.
  • Eslinger, Cameron, Dumais, Imardjoko, Marsoem, McIntyre, et al. (2015). Source term estimates of radioxenon released from the BaTek medical isotope production facility using external measured air concentrations. Journal of Environmental Radioactivity, 148, 10-15.
  • Gueibe, Kalinowski, Bare, Gheddou, Krysta, & Kusmierczyk-Michulec (2017). Setting the baseline for estimated background observations at IMS systems of four radioxenon isotopes in 2014. Journal of Environmental Radioactivity, 178, 297-314.
  • Hoffman, & Berg (2018). Medical isotope production, research reactors and their contribution to the global xenon background. Journal of Radioanalytical and Nuclear Chemistry, 318(1), 165-173.
  • Hoffman, Ungar, Bean, Yi, Servranckx, Zaganescu, et al. (2009). Changes in radioxenon observations in Canada and Europe during medical isotope production facility shut down in 2008. Journal of Radioanalytical and Nuclear Chemistry, 282(3), 767-772.
  • Johnson, C., et al., Production and release rate of 37Ar from the UT TRIGA Mark-II research reactor. Journal of Environmental Radioactivity, 2017. 167: p. 249-253.
  • Johnson, Biegalski, Haas, Lowrey, Bowyer, Hayes, et al. (2017). Detection in subsurface air of radioxenon released from medical isotope production. Journal of Environmental Radioactivity, 167, 160-165.
  • Johnson, Lowrey, Biegalski, & Haas (2015). Regional transport of radioxenon released from the Chalk River Laboratories medical isotope facility. Journal of Radioanalytical and Nuclear Chemistry, 305(1), 207-212.
  • Kalinowski, Grosch, & Hebel (2014). Global Xenon-133 Emission Inventory Caused by Medical Isotope Production and Derived from the Worldwide Technetium-99m Demand. Pure and Applied Geophysics, 171(3-5), 707-716.
  • Kalinowski, & Liao (2014). Isotopic Characterization of Radioiodine and Radioxenon in Releases from Underground Nuclear Explosions with Various Degrees of Fractionation. Pure and Applied Geophysics, 171(3-5), 677-692.
  • LeBlanc, D. and C. Rodenburg, 18 - Integral molten salt reactor, in Molten Salt Reactors and Thorium Energy, T.J. Dolan, Editor. 2017, Woodhead Publishing. p. 541-556.
  • Miley, H.S., et al., The potential detection of low-level aerosol isotopes from new civilian nuclear processes. Applied Radiation and Isotopes, 2017. 126: p. 232-236.
  • Saey (2009). The influence of radiopharmaceutical isotope production on the global radioxenon background. Journal of Environmental Radioactivity, 100(5), 396-406.
  • Saey, Auer, Becker, Hoffmann, Nikkinen, Ringbom, et al. (2010). The influence on the radioxenon background during the temporary suspension of operations of three major medical isotope production facilities in the Northern Hemisphere and during the start-up of another facility in the Southern Hemisphere. Journal of Environmental Radioactivity, 101(9), 730-738.
  • Serp, J., et al., The molten salt reactor (MSR) in generation IV: overview and perspectives. Progress in Nuclear Energy, 2014. 77: p. 308-319.
  • Wotawa, Becker, Kalinowski, Saey, Tuma, & Zahringer (2010). Computation and Analysis of the Global Distribution of the Radioxenon Isotope Xe-133 based on Emissions from Nuclear Power Plants and Radioisotope Production Facilities and its Relevance for the Verification of the Nuclear-Test-Ban Treaty. Pure and Applied Geophysics, 167(4-5), 541-557.
Last Updated: September 2021